Stocks Health care ADVB
NASDAQ · Health careAdvanced Biomed Inc. (ADVB)
In fiscal 2025 capital spending exceeded operating cash flow by $5.9M. At March 31, 2026 it held $2.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 15, 2026.
What Advanced Biomed Inc. does
Advanced Biomed Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker ADVB.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$3.3M | -$0.16 | -$5.9M |
| 2025 | n/a | -$2.8M | -$0.14 | -$2.2M |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Advanced Biomed Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 22, 2026Passive stake (5% or more) SCHEDULE 13G
- August 20, 2026Passive stake changed SCHEDULE 13G/A
- August 20, 2026Passive stake (5% or more) SCHEDULE 13G
- July 20, 2026
- July 17, 2026
- July 1, 2026
- June 30, 2026
- June 4, 2026Proxy statement DEF 14A
- May 15, 2026
- May 1, 2026
Insider trades
What the people running Advanced Biomed Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 27, 2026 | Pau Hung To10% owner | Other change | 100,000 | $48B |
| July 27, 2026 | Pau Hung To10% owner | Other change | 76,225 | $36.59B |
Who owns ADVB
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Lee Chen YI13G, passive with 1 related filers | 7.5% | September 22, 2026 |
Largest institutional holders
Insiders
Questions about ADVB
What does Advanced Biomed Inc. do?
Advanced Biomed Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker ADVB.
Is Advanced Biomed Inc. profitable?
Yes. Over the twelve months to March 31, 2026 it reported net income of $5.3M.
When did Advanced Biomed Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on May 15, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the passive stake (5% or more) from September 22, 2026.
Similar companies
Compare ADVB with
Follow ADVB
Get an email when Advanced Biomed Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow ADVB: get an email when it filesWhere the numbers come from
Financial figures are the values Advanced Biomed Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.